中国临床药理学杂志2024,Vol.40Issue(21) :3171-3175.DOI:10.13699/j.cnki.1001-6821.2024.21.021

硫化氢防治胃肠道缺血再灌注损伤的研究现状

Research status of hydrogen sulfide in the prevention and treatment of gastrointestinal ischemia-reperfusion injury

吴思雨 孙许涛 曹硕 毛彩云 周淇 宋运佳
中国临床药理学杂志2024,Vol.40Issue(21) :3171-3175.DOI:10.13699/j.cnki.1001-6821.2024.21.021

硫化氢防治胃肠道缺血再灌注损伤的研究现状

Research status of hydrogen sulfide in the prevention and treatment of gastrointestinal ischemia-reperfusion injury

吴思雨 1孙许涛 1曹硕 1毛彩云 1周淇 1宋运佳1
扫码查看

作者信息

  • 1. 黑龙江中医药大学基础医学院,黑龙江哈尔滨 150000
  • 折叠

摘要

胃肠道缺血再灌注(I/R)损伤是外科创伤患者高发病率和死亡率的主要原因.作为第3种气体信号分子,硫化氢(H2S)在人体胃肠道系统发挥重要的病理生理作用.多种新型H2S供体如ATB-344、AP39对胃肠道I/R损伤具有治疗价值.本文综述了H2S供体对胃肠道I/R损伤保护作用及其作用机制,旨在为胃肠道I/R损伤提供新的治疗方法,以期对其临床用药提供参考.

Abstract

Gastrointestinal ischemia reperfusion(I/R)injury is a major cause of high morbidity and mortality in patients with surgical trauma.At present,there are few studies on gastrointestinal I/R injury,so it is particularly important to find treatment methods for gastrointestinal I/R injury.As the third gas signaling molecule,H2S plays an important physiological and pathological role in the human gastrointestinal system.Recently,a variety of novel H2S donors such as ATB-344 and AP39 have shown therapeutic value for gastrointestinal I/R injury.Therefore,this article reviewed the treatment of gastrointestinal I/R injury by H2S donors and its mechanism of action,aiming to provide a new treatment method for gastrointestinal I/R injury,in order to provide a reference for clinical medication of gastrointestinal I/R injury.

关键词

硫化氢/硫化氢供体/胃肠道缺血再灌注损伤/防治

Key words

hydrogen sulfide/hydrogen sulfide donor/gastrointestinal ischemia-reperfusion injury/prevention and cure

引用本文复制引用

出版年

2024
中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCDCSCD北大核心
影响因子:1.91
ISSN:1001-6821
段落导航相关论文